A Cross-Sectional Study on the Quality of Life in Women with Endometrioma

Thammasiri, Chutikarn; Amnatbuddee, Siriruthai; Sothornwit, Jen; Temtanakitpaisan, Teerayut; Buppasiri, Pranom

doi:10.2147/ijwh.s341603

Cited by 6 publications

(6 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The HRQoL of patients with endometriosis was negatively correlated with anxiety and depression ( 19 , 40 , 43 , 46 ). Facchin et al ( 15 ) reported a strong association between sleep disturbances and poorer psychological health and quality of life in women with endometriosis.…”

Section: Resultsmentioning

confidence: 99%

The impact of endometriosis on depressive and anxiety symptoms and quality of life: a systematic review

Szypłowska,

Tarkowski,

Kułak

2023

Front. Public Health

View full text Add to dashboard Cite

IntroductionEndometriosis is a common gynecological disorder affecting approximately 10–15% of women of reproductive age. The main complaints of patients with endometriosis are pain and fertility problems. Symptoms of endometriosis can impact the psychological functioning of the patients and significantly compromise their mental health.Methods The aim of this review was to assess the prevalence of depressive and anxiety symptoms and quality of life in endometriosis patients. For this systematic review, we searched the PubMed, MEDLINE, ProQuest, EMBASE, Cochrane, CINAHL, Google Scholar, Scopus, and ScienceDirect electronic databases up to March 2023 to identify potentially relevant studies. The systematic review in the present paper is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidance.ResultsOf four records identified, 18 were eligible to be reviewed on the association between endometriosis and symptoms of depression and anxiety. Of 8,901 records identified, 28 were reviewed on the association between endometriosis and quality of life. The reviewed articles showed a prevalence ranging from 9.8 to 98.5% for depressive symptoms and 11.5 to 87.5% for anxiety. The quality of life in patients with endometriosis was significantly impaired, regardless of the tool used for evaluation.DiscussionThis systematic review shows that endometriosis is associated with depressive and anxiety symptoms and impaired HRQoL. Broad correlating factors modulate mental health outcomes, indicating the complex relationship between the disease and the psychological health of the patients.

show abstract

Section: Resultsmentioning

confidence: 99%

The impact of endometriosis on depressive and anxiety symptoms and quality of life: a systematic review

Szypłowska,

Tarkowski,

Kułak

2023

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…Ovarian chocolate-like cysts or endometriomas are a major pathological manifestation of endometriosis, occurring in approximately 17–44% of women diagnosed with endometriosis [ 1 ]. While ovarian endometriomas may adversely affect quality of life and work performance, to the best of our knowledge, the association between cyst size and the pain in women with ovarian endometriomas has not been elucidated [ 2 ]. Therefore, in this retrospective study, we assessed the association between clinical epidemiological background and ovarian endometriomas, focusing on the association among age, ovarian endometrioma size, and pain, using data from patients enrolled in six prospective clinical studies [ 3 – 5 ].…”

Section: Introductionmentioning

confidence: 99%

Evaluation of the Characteristics of Ovarian Endometriomas in Patients with Endometriosis: Efficacy of a Low-Dose Estrogen/Progestogen Combination

Komatsu,

Sunada,

Endo

et al. 2023

Gynecol Obstet Invest

View full text Add to dashboard Cite

Objectives: Approximately 17–44% of women diagnosed with endometriosis have ovarian endometriomas (cysts). Although ovarian endometriomas may adversely affect quality of life and work performance, no reports have been published on the relationship between patient characteristics, cyst size, and pain associated with ovarian endometriomas. The objective of this study was to assess the association between age, cyst size, and pain in women with ovarian endometriomas. Design: Retrospective secondary analysis of pooled data from six randomized clinical trials of the use of low-dose estrogen/progestogen drugs for endometriosis. Participants/Materials, Setting, Methods: Data on 491 patients enrolled in four randomized and two non-randomized trials between 2003 and 2017, who had not undergone surgical treatment prior to trial participation, were pooled. We examined differences in the dysmenorrhea score, menstrual pain score, analgesic score, and visual analog scale (VAS) by age and endometrioma size. Results The mean dysmenorrhea, menstrual pain, and analgesic scores were 4.2, 2.2, and 2.0, respectively. The mean VAS for pelvic pain was 55, which decreased significantly with increasing age. There was no correlation between age and endometrioma size, the dysmenorrhea score and the endometrioma volume or maximum diameter. In addition, there was no correlation between menstrual pain, analgesic score, or VAS and the endometrioma volume or maximum diameter. Limitations The details of past treatment history were not available; therefore, these could not be considered in the analysis. In addition, the assessment of pain is heavily influenced by psychological aspects, making it difficult to assess the true extent of pain. Conclusions Endometrioma size was unrelated to dysmenorrhea or pelvic pain measured using the VAS.

show abstract

“…The cardinal symptoms of endometriosis are primary or secondary dysmenorrhea, chronic recurrent abdominal pain, pain during sexual intercourse, abdominal distension, dysuria and infertility [15][16][17] . Various studies have shown that endometriosis reduces the quality of life of affected women [1,18,19] . In addition to having physical, mental and social consequences for affected women at the individual level [12], endometriosis is estimated to have signi cant economic impacts on society as a whole [20][21][22], due mainly to increased healthcare utilization and reduced work productivity [21,23,24] .…”

Section: Introductionmentioning

confidence: 99%

Cross-sectional study for derivation of a cut-off value for identification of a timely versus late diagnosis of endometriosis based on analytical and descriptive research methods

Brandes

Kleine-Budde

Heinze

et al. 2022

Preprint

View full text Add to dashboard Cite

BackgroundEndometriosis is a benign, hormone-dependent, chronic inflammatory gynecological disease accompanied by cyclic and acyclic pelvic pain and other complaints. The long lists of research recommendations in the AWMF guideline [5] and ESHRE Endometriosis Guideline [6] show that there is still a great need for research in all aspects of the disease. Diagnostic delay, defined as the mean time between symptom onset and confirmed diagnosis, is a particular problem associated with endometriosis. Some quantitative and qualitative studies have investigated possible reasons for this. A range of physician-related [7, 8] and patient-related factors [9] as well as stigmatization of the topic of menstruation by society have been identified [10, 11]. The consequences of the disease being diagnosed late (or too late) on the course of disease, the quality of life and the costs of the disease have already been documented in studies [12, 13]. However, a systematically derived cut-off value that clearly distinguishes between short and long delay is still lacking. Therefore, the aim of our study was to derive a threshold value for the definition of a target corridor for endometriosis diagnosis based on descriptive and analytical methods.MethodsSince our review of the rather sparse publications on diagnostic delay did not yield satisfactory results, we used descriptive statistics and location parameters to calculate a cut-off value for German population data from the EndoCost study. Statistical methods were used for correlation analysis of shortDD versus longDD (correlation analysis and logistic regression) and group membership (discriminant analysis). ResultsFive years was identified as the cut-off value that significantly differentiated between shortDD and longDD based on various disease-related variables. This suggests that endometriosis should be definitively diagnosed within less than five years to minimize the risk of an unfavorable course of the disease. Our findings confirmed that an early onset of endometriosis-related symptoms is the most important risk factor for a long diagnostic delay. Consequently, adolescent females should receive increased attention as an especially vulnerable group. Evidently, there is an urgent need to develop adequate concepts to improve the endometriosis education and care among this target group.

show abstract

A Cross-Sectional Study on the Quality of Life in Women with Endometrioma

Cited by 6 publications

References 29 publications

The impact of endometriosis on depressive and anxiety symptoms and quality of life: a systematic review

The impact of endometriosis on depressive and anxiety symptoms and quality of life: a systematic review

Evaluation of the Characteristics of Ovarian Endometriomas in Patients with Endometriosis: Efficacy of a Low-Dose Estrogen/Progestogen Combination

Cross-sectional study for derivation of a cut-off value for identification of a timely versus late diagnosis of endometriosis based on analytical and descriptive research methods

Contact Info

Product

Resources

About